nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An insight on how to survive COVID-19
|
Worrell, Rose |
|
|
21 |
12 |
p. 1643 |
artikel |
2 |
Antibiotics for neonatal sepsis in low-income and middle-income countries—where to go from here?
|
Schlapbach, Luregn J |
|
|
21 |
12 |
p. 1617-1618 |
artikel |
3 |
An urgent need: vaccines for neglected tropical diseases
|
Anderson, Roy M |
|
|
21 |
12 |
p. 1621-1623 |
artikel |
4 |
Assessing the evidence on remdesivir
|
Trøseid, Marius |
|
|
21 |
12 |
p. 1630-1631 |
artikel |
5 |
Assessing the evidence on remdesivir
|
Núñez, Isaac |
|
|
21 |
12 |
p. 1630 |
artikel |
6 |
Can financial rewards for stewardship in primary care curb antibiotic resistance?
|
Lawandi, Alexander |
|
|
21 |
12 |
p. 1618-1620 |
artikel |
7 |
Chloroquine-resistant Plasmodium falciparum in Pakistan
|
Khattak, Aamer Ali |
|
|
21 |
12 |
p. 1632 |
artikel |
8 |
Chronic cavitary pulmonary aspergillosis in an infant
|
Liu, Zhongqiang |
|
|
21 |
12 |
p. 1757 |
artikel |
9 |
Chronicling PEPFAR's work in Africa
|
Balakrishnan, Vijay Shankar |
|
|
21 |
12 |
p. 1642 |
artikel |
10 |
Clindamycin-resistant Streptococcus pyogenes in Chinese children
|
Yu, Dingle |
|
|
21 |
12 |
p. 1631-1632 |
artikel |
11 |
Complexities in the treatment of coinfection with HIV, hepatitis B, hepatitis C, and tuberculosis
|
Arora, Umang |
|
|
21 |
12 |
p. e399-e406 |
artikel |
12 |
Correction to Lancet Infect Dis 2021; 21: 929–38
|
|
|
|
21 |
12 |
p. e363 |
artikel |
13 |
Correction to Lancet Infect Dis 2021; online Sept 14. https://doi.org/10.1016/S1473-3099(21)00472-2
|
|
|
|
21 |
12 |
p. e363 |
artikel |
14 |
Correction to Lancet Infect Dis 2021; published online Aug 19. https://doi.org/10.1016/S1473-3099(21)00203-6
|
|
|
|
21 |
12 |
p. e363 |
artikel |
15 |
Correction to Lancet Infect Dis 2021; published online Oct 28. https://doi.org/10.1016/S1473-3099(21)00648-4
|
|
|
|
21 |
12 |
p. e363 |
artikel |
16 |
Correction to Lancet Infect Dis 2021; published online Oct 11. https://doi.org/10.1016/S1473-3099(21)00458-8
|
|
|
|
21 |
12 |
p. e363 |
artikel |
17 |
Correction to Lancet Infect Dis 2021; published online Oct 4, https://doi.org/10.1016/S1473-3099(21)00565-X
|
|
|
|
21 |
12 |
p. e363 |
artikel |
18 |
COVID-19 vaccination in pregnancy—number needed to vaccinate to avoid harm
|
Magee, Laura A |
|
|
21 |
12 |
p. 1627 |
artikel |
19 |
COVID-19 vaccine intentions in Australia
|
Pickles, Kristen |
|
|
21 |
12 |
p. 1627-1628 |
artikel |
20 |
COVID-19 vaccine intentions in Australia
|
Edwards, Benjamin |
|
|
21 |
12 |
p. 1628-1629 |
artikel |
21 |
COVID-19 vaccines for children younger than 12 years: are we ready?
|
Zou, Xiaohui |
|
|
21 |
12 |
p. 1614-1615 |
artikel |
22 |
Defeating meningitis by 2030: the WHO roadmap
|
Venkatesan, Priya |
|
|
21 |
12 |
p. 1635 |
artikel |
23 |
Dismal global tuberculosis situation due to COVID-19
|
Bagcchi, Sanjeet |
|
|
21 |
12 |
p. 1636 |
artikel |
24 |
Effect of antibiotic stewardship interventions in primary care on antimicrobial resistance of Escherichia coli bacteraemia in England (2013–18): a quasi-experimental, ecological, data linkage study
|
Aliabadi, Shirin |
|
|
21 |
12 |
p. 1689-1700 |
artikel |
25 |
Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004–18
|
Chow, Eric P F |
|
|
21 |
12 |
p. 1747-1756 |
artikel |
26 |
Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS)
|
Thomson, Kathryn M |
|
|
21 |
12 |
p. 1677-1688 |
artikel |
27 |
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM
|
Chen, Sharon C-A |
|
|
21 |
12 |
p. e375-e386 |
artikel |
28 |
Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology
|
Thompson III, George R |
|
|
21 |
12 |
p. e364-e374 |
artikel |
29 |
How reliable are COVID-19 burden estimates for India?
|
Li, You |
|
|
21 |
12 |
p. 1615-1617 |
artikel |
30 |
Increased risk of hospitalisation and death with the delta variant in the USA
|
Bast, Elizabeth |
|
|
21 |
12 |
p. 1629-1630 |
artikel |
31 |
Infectious disease surveillance update
|
Islam, Tanzina |
|
|
21 |
12 |
p. 1638 |
artikel |
32 |
Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis
|
Rustage, Kieran |
|
|
21 |
12 |
p. 1701-1712 |
artikel |
33 |
Investigating the origins of novel pathogens
|
Samarasekera, Udani |
|
|
21 |
12 |
p. 1633 |
artikel |
34 |
Leaving—poetry is my companion
|
Golshaie, Asal |
|
|
21 |
12 |
p. 1644 |
artikel |
35 |
Long-term consequences of the misuse of ivermectin data
|
Alvarez-Moreno, Carlos |
|
|
21 |
12 |
p. 1624-1626 |
artikel |
36 |
Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review
|
Deal, Anna |
|
|
21 |
12 |
p. e387-e398 |
artikel |
37 |
Minoo Mohraz—Iran's leader in HIV research
|
Samarasekera, Udani |
|
|
21 |
12 |
p. 1640 |
artikel |
38 |
Neisseria meningitidis-induced discitis at L5-S1 mimicking lumbar disc herniation
|
Hoppe, Sven |
|
|
21 |
12 |
p. 1758 |
artikel |
39 |
NHS Test and Trace’s aims “overstated or not achieved”
|
Burki, Talha |
|
|
21 |
12 |
p. 1637-1638 |
artikel |
40 |
Philippa Musoke—stop mother-to-child HIV transmission
|
Kirby, Tony |
|
|
21 |
12 |
p. 1641 |
artikel |
41 |
Research in brief
|
Devi, Sharmila |
|
|
21 |
12 |
p. 1639 |
artikel |
42 |
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study
|
McCarthy, James S |
|
|
21 |
12 |
p. 1713-1724 |
artikel |
43 |
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
|
Wu, Shipo |
|
|
21 |
12 |
p. 1654-1664 |
artikel |
44 |
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial
|
Han, Bihua |
|
|
21 |
12 |
p. 1645-1653 |
artikel |
45 |
SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study
|
Laxminarayan, Ramanan |
|
|
21 |
12 |
p. 1665-1676 |
artikel |
46 |
Save our only planet
|
The Lancet Infectious Diseases, |
|
|
21 |
12 |
p. 1613 |
artikel |
47 |
The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation
|
Currie, Bart J |
|
|
21 |
12 |
p. 1737-1746 |
artikel |
48 |
The value of open-source clinical science in pandemic response: lessons from ISARIC
|
|
|
|
21 |
12 |
p. 1623-1624 |
artikel |
49 |
Towards the next generation of antimalaria combination therapies
|
Möhrle, Jörg J |
|
|
21 |
12 |
p. 1620-1621 |
artikel |
50 |
Vaccination of human participants with attenuated Necator americanus hookworm larvae and human challenge in Australia: a dose-finding study and randomised, placebo-controlled, phase 1 trial
|
Chapman, Paul R |
|
|
21 |
12 |
p. 1725-1736 |
artikel |
51 |
WHO recommends malaria vaccine for children
|
Balakrishnan, Vijay Shankar |
|
|
21 |
12 |
p. 1634 |
artikel |